Skip to main content
Sheng Cai, MD, Oncology, New York, NY

ShengFengCaiMDPhD

Oncology • New York, NY

Hematologic Oncology

Instructor of Medicine at Memorial Sloan Kettering Cancer Center

Request Appointment

Overview of Dr. Cai

Dr. Sheng Cai is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Washington University in St. Louis School of Medicine and has been in practice 6 years. He is one of 508 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 30 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2017
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2011 - 2013
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 2011

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2012 - 2026
  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Article HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis  
    Ross L Levine, Jay L Hess, Sheng Cai, Scott A Armstrong, ScienceDirect

Abstracts/Posters

  • A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination with Azacitidine in Patients with 11q23-Rearranged Acute Myeloid Leukemia
    Sheng F Cai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent Mechanism
    Sheng F. Cai, MD, PhD, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Dr. Sheng Cai, Dr. Sheng Cai, MD, Dr. S Cai, Dr. Sheng Feng Cai